SEC Form 4 · accession 0001179110-15-003864
SUNESIS PHARMACEUTICALS INC · SNSS
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Eric Bjerkholt
Officer — EVP, CFO & Corp. Secretary
Period of report
Feb 27, 2015
Accepted (ET)
Mar 2, 2015 · 7:47 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001061027
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Feb 27, 2015 | A | 17,642 | $0.00 | A | 57,636 | D | |
| Common Stock | Feb 27, 2015 | F | 7,723 | $2.22 | D | 49,913 | D | |
| Common StockF1 | holding | — | — | — | 73,529 | I | See footnote |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1The Shares are held by the Bjerkholt/Hahn Family Trust for which reporting person is the Trustee.